| Financial Year |
March 31 2023 |
| Monetary Funds |
211,884,371.74 |
| Held-for-trading Financial Assets |
657,272,179.05 |
| Notes Receivable |
11,078,810.90 |
| Accounts Receivable |
290,120,936.74 |
| Advances to Suppliers |
2,909,092.33 |
| Other Receivables |
3,383,603.20 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
136,795,106.96 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
914,000.00 |
| Other Current Assets |
42,999,819.42 |
| Total Current Assets |
1,358,570,255.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
256,928.88 |
| Fixed Assetes |
600,305,399.78 |
| Under-construction Projects |
1,562,172.32 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
72,083,515.71 |
| R&D expenses |
-- |
| Goodwill |
6,304,757.53 |
| Long-Term Deferred and Prepaid Expenses |
18,963,673.45 |
| Deferred Income Tax Assets |
5,109,311.96 |
| Other Non-Current Assets |
7,723,324.59 |
| Sub-Total of Non-Current Assets |
715,809,108.44 |
| Total Assets |
2,074,379,363.52 |
| Short-Term Loans |
35,694,000.08 |
| Trading Financial liabilities |
-- |
| Notes Payable |
37,563,111.06 |
| Accounts Payable |
222,114,013.44 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,046,012.92 |
| Taxes Payable |
8,200,976.58 |
| Interest Payable |
-- |
| Dividend Payable |
500,000.00 |
| Other payables |
10,978,614.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,386,641.87 |
| Other Current Liabilities |
45,685.41 |
| Sub-Total of Current Liabilities |
334,533,578.89 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
757,900.48 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,927,995.76 |
| Total Liabilities |
337,461,574.65 |
| Paid-In Capital(Or Share Stock) |
280,852,507.00 |
| Capital Surplus |
898,433,072.82 |
| Surplus Reserve |
80,163,788.84 |
| LESS:Treasury Stock |
19,962,906.00 |
| Undistributed Profits |
489,429,900.52 |
| Minority Stockholder's Interest |
8,573,755.66 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,728,344,033.21 |
| Owner's Equity（Stockholder's Equity） |
1,736,917,788.87 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,074,379,363.52 |
